The glycine/NMDA receptor antagonist, R‐(+)‐HA‐966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK‐801) in rodents
Open Access
- 1 April 1993
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 108 (4) , 1156-1163
- https://doi.org/10.1111/j.1476-5381.1993.tb13520.x
Abstract
1 The effects of the glycine/N-methyl-d-aspartate (NMDA) receptor antagonist, R-(+)-HA-966 on the neurochemical and behavioural responses to phencyclidine (PCP) and dizocilpine (MK-801) have been determined in rodents. 2 In rats, pretreatment with PCP (5 and 10 mg kg−1) or MK-801 (0.25 and 0.5 mg kg−1) dose-dependently stimulated dopamine turnover in nucleus accumbens, amygdala and medial prefrontal cortex, but had no effect in striatum. In contrast, pretreatment with (+)-HA-966 (10 and 30 mg kg−1) did not affect dopamine turnover in any brain region investigated. 3 Pretreatment with (+)-HA-966 (10 and 30 mg kg−1) significantly antagonized the stimulation of dopamine turnover induced by both PCP (10 mg kg−1) and MK-801 (0.5 mg kg−1) in rat nucleus accumbens, amygdala and medial prefrontal cortex. 4 Intracerebral dialysis studies in conscious rats demonstrated that systemic injection of PCP (10 mg kg−1) markedly stimulated dopamine release from the nucleus accumbens, an effect that was abolished by pretreatment with (+)-HA-966 (30 mg kg−1). 5 Pretreatment with PCP (3–30 mg kg−1) or MK-801 (0.1–1.6 mg kg−1) significantly increased locomotor activity in mice. In contrast, subcutaneous injection of (+)-HA-966 (10–100 mg kg−1) failed to stimulate activity. 6 Pretreatment with (+)-HA-966 (10 and 30 mg kg−1) dose-dependently antagonized both PCP (10 mg kg−1) and MK-801 (0.4 mg kg−1) induced hyperactivity in mice. 7 Blockade of PCP-induced hyperactivity by (+)-HA-966 is unlikely to be explained by the induction or potentiation of sedation/ataxia since PCP-induced rotarod deficits were not significantly different in mice pretreated with (+)-HA-966 (30 mg kg−1) or saline. 8 The results demonstrate that (+)-HA-966 antagonizes both the neurochemical and behavioural effects of PCP and MK-801, possibly through interactions at the glycine/NMDA receptor.Keywords
This publication has 52 references indexed in Scilit:
- Effects of competitive antagonists on midbrain dopamine neurons: An electrophysiological and behavioral comparison to phencyclidineNeuropharmacology, 1991
- Differential Interaction of Phencyclidine‐Like Drugs with the Dopamine Uptake Complex In VivoJournal of Neurochemistry, 1991
- Activation of postsynaptic striatal dopamine receptors, monitored by efflux of cAMP in vivoNeuropharmacology, 1990
- Hyperactivity induced by N-methyl-d-aspartate injections into nucleus accumbens: Lack of evidence for mediation by dopaminergic neuronsPharmacology Biochemistry and Behavior, 1989
- Differential effects of phencyclidine (PCP) and ketamine on mesocortical and mesostriatal dopamine releaseLife Sciences, 1989
- Glycine modulation of NMDA-evoked release of [3H]acetylcholine and [3H]dopamine from rat striatal slicesNeuroscience Letters, 1989
- The discriminative stimulus effects of N-methyl-d-aspartate antagonists in phencyclidine-trained ratsNeuropharmacology, 1988
- [3H]MK‐801 Labels a Site on the N‐Methyl‐D‐Aspartate Receptor Channel Complex in Rat Brain MembranesJournal of Neurochemistry, 1988
- Stimulatory effect of N-methyl aspartate on locomotor activity and transmitter release from rat nucleus accumbensPharmacology Biochemistry and Behavior, 1986
- Effects of excitatory amino acids on locomotor activity after bilateral microinjection into the rat nucleus accumbens: Possible dependence on dopaminergic mechanismsNeuropharmacology, 1983